Open Access

Inflammation in atherosclerosis: time for translation?

Congress Presentation

About the speaker

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
36 presentations
6 followers

5 more presentations in this session

Welcome and Introduction - Emerging evidence-based approaches to reduce residual atherosclerotic risk.

Speaker: Professor W. Koenig (Munich, DE)

Thumbnail

Identification of residual inflammatory cardiovascular risk.

Speaker: Doctor J. Cornel (Alkmaar, NL)

Thumbnail

Therapeutic strategies for secondary cardiovascular disease prevention.

Speaker: Doctor P. Ridker (Boston, US)

Thumbnail

Audience Q&A and panel discussion.

Speaker: Professor W. Koenig (Munich, DE) Professor P. Libby (Boston, US) Doctor P. Ridker (Boston, US) Doctor J. Cornel (Alkmaar, NL)

Thumbnail

Learning points and close - Emerging evidence-based approaches to reduce residual atherosclerotic risk.

Speaker: Professor W. Koenig (Munich, DE)

Thumbnail

Access the full session

Emerging evidence-based approaches to reduce residual atherosclerotic risk

Speakers: Professor P. Libby, Professor W. Koenig, Doctor J. Cornel, Doctor P. Ridker, Professor W. Koenig...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb